Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)

Q4 2021 13F Holders as of 12/31/2021

Type / Class
Equity / Common Stock
Shares outstanding
10.6M
Number of holders
16
Total 13F shares, excl. options
1.27M
Shares change
-722K
Total reported value, excl. options
$2.95M
Value change
-$3.47M
Put/Call ratio
54
Number of buys
11
Number of sells
-6
Price
$2.33

Significant Holders of Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) as of Q4 2021

24 filings reported holding ARDS - Aridis Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.27M shares of 10.6M outstanding shares and own 11.95% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (507K shares), Roumell Asset Management, LLC (447K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (54.7K shares), BlackRock Inc. (43.2K shares), JANE STREET GROUP, LLC (39.7K shares), GEODE CAPITAL MANAGEMENT, LLC (38K shares), STATE STREET CORP (26.4K shares), PERRITT CAPITAL MANAGEMENT INC (24K shares), COMMONWEALTH EQUITY SERVICES, LLC (20.2K shares), and NORTHERN TRUST CORP (16.6K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.